Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients.

@article{Derosa2011ComparisonBO,
  title={Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients.},
  author={Giuseppe Derosa and Pamela Maffioli and Ilaria Ferrari and Angela D'Angelo and Elena Fogari and Ilaria Palumbo and Sabrina Randazzo and Arrigo Francesco Giuseppe Cicero},
  journal={Fundamental & clinical pharmacology},
  year={2011},
  volume={25 5},
  pages={642-51}
}
To evaluate the effects of 1-year treatment with orlistat plus L-carnitine compared to orlistat alone on body weight, glycemic and lipid control, and inflammatory parameters in obese type 2 diabetic patients. Two hundred and fifty-eight patients with uncontrolled type 2 diabetes mellitus (T2DM) [glycated hemoglobin (HbA(1c)) > 8.0%] in therapy with different oral hypoglycemic agents or insulin were enrolled in this study and randomized to take orlistat 120 mg three times a day plus L-carnitine… CONTINUE READING